Abstract
In the post-genome era, designing and conducting novel experiments have become increasingly common for modern researchers. However, the major challenge faced by researchers is surprisingly not the complexity in designing new experiments or obtaining the data generated from the experiments, but instead it is the huge amount of data to be processed and analyzed in the quest to produce meaningful information and knowledge. Gene regulatory network (GRN) inference from gene expression data is one of the common examples of such challenge. Over the years, GRN inference has witnessed a number of transitions, and an increasing amount of new computational and statistical-based methods have been applied to automate the procedure. One of the widely used approaches for GRN inference is the dynamic Bayesian network (DBN). In this review paper, we first discuss the evolution of molecular biology research from reductionism to holism. This is followed by a brief insight on various computational and statistical methods used in GRN inference before focusing on reviewing the current development and applications of DBN-based methods.
Keywords: Dynamic bayesian network, gene regulatory networks, network inference, time-series gene expression data.
Current Bioinformatics
Title:Current Development and Review of Dynamic Bayesian Network-Based Methods for Inferring Gene Regulatory Networks from Gene Expression Data
Volume: 9 Issue: 5
Author(s): Lian En Chai, Mohd Saberi Mohamad, Safaai Deris, Chuii Khim Chong, Yee Wen Choon and Sigeru Omatu
Affiliation:
Keywords: Dynamic bayesian network, gene regulatory networks, network inference, time-series gene expression data.
Abstract: In the post-genome era, designing and conducting novel experiments have become increasingly common for modern researchers. However, the major challenge faced by researchers is surprisingly not the complexity in designing new experiments or obtaining the data generated from the experiments, but instead it is the huge amount of data to be processed and analyzed in the quest to produce meaningful information and knowledge. Gene regulatory network (GRN) inference from gene expression data is one of the common examples of such challenge. Over the years, GRN inference has witnessed a number of transitions, and an increasing amount of new computational and statistical-based methods have been applied to automate the procedure. One of the widely used approaches for GRN inference is the dynamic Bayesian network (DBN). In this review paper, we first discuss the evolution of molecular biology research from reductionism to holism. This is followed by a brief insight on various computational and statistical methods used in GRN inference before focusing on reviewing the current development and applications of DBN-based methods.
Export Options
About this article
Cite this article as:
Chai En Lian, Mohamad Saberi Mohd, Deris Safaai, Chong Khim Chuii, Choon Wen Yee and Omatu Sigeru, Current Development and Review of Dynamic Bayesian Network-Based Methods for Inferring Gene Regulatory Networks from Gene Expression Data, Current Bioinformatics 2014; 9 (5) . https://dx.doi.org/10.2174/1574893609666140421210333
DOI https://dx.doi.org/10.2174/1574893609666140421210333 |
Print ISSN 1574-8936 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-392X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
New Therapies for Prostate Cancer Based on the Biology of Androgen Receptor Coregulators
Current Cancer Therapy Reviews Peptide-Receptor Ligands and Multivalent Approach
Anti-Cancer Agents in Medicinal Chemistry The Inverse Relationship Between Cancer and Alzheimer's Disease: A Possible Mechanism
Current Alzheimer Research From Bortezomib to other Inhibitors of the Proteasome and Beyond
Current Pharmaceutical Design Recent Developments in Anti-Cancer Agents Targeting the Ras/Raf/ MEK/ERK Pathway
Recent Patents on Anti-Cancer Drug Discovery Measles Virus as An Oncolytic Vector Platform
Current Gene Therapy Extracellular Vesicles as Novel Delivery Tools for Cancer Treatment
Current Cancer Drug Targets Potential Uses of MicroRNA in Lung Cancer Diagnosis, Prognosis, and Therapy
Current Cancer Drug Targets Anti-EGFRvIII Chimeric Antigen Receptor-Modified T Cells for Adoptive Cell Therapy of Glioblastoma
Current Pharmaceutical Design Recent Advances in Cancer Drug Development: Targeting Induced Myeloid Cell Leukemia-1 (Mcl-1) Differentiation Protein
Current Medicinal Chemistry Double-Edged Sword of Novel Anti-Cancer Treatment: Proteasome Inhibition in the Growth Plate Causes Impairment of Longitudinal Bone Growth
Current Pediatric Reviews Tumor-Targeting Peptides: Ligands for Molecular Imaging and Therapy
Anti-Cancer Agents in Medicinal Chemistry Antisynthetase Syndrome: A Review of Etiopathogenesis, Diagnosis and Management
Current Medicinal Chemistry Role of CGRP-Receptor Component Protein (RCP) in CLR/RAMP Function
Current Protein & Peptide Science Intraperitoneal Chemotherapy as Primary Treatment of Advanced Ovarian Cancer:Efficacy, Toxicity, and Future Directions
Reviews on Recent Clinical Trials DNA Methylation and miRNAs Regulation in Hereditary Breast Cancer: Epigenetic Changes, Players in Transcriptional and Post- Transcriptional Regulation in Hereditary Breast Cancer
Current Molecular Medicine Role of Calcium, Vitamin D, and the Extrarenal Vitamin D Hydroxylases in Carcinogenesis
Anti-Cancer Agents in Medicinal Chemistry Recent Nanocarrier Approaches for Targeted Drug Delivery in Cancer Therapy
Current Molecular Pharmacology Ligand-Targeted Liposomal Therapies of Neuroblastoma
Current Medicinal Chemistry Stem Cell-based Tissue Engineering Approaches for Musculoskeletal Regeneration
Current Pharmaceutical Design